Location History:
- E. Windsor, NJ (US) (2002 - 2004)
- East Windsor, NJ (US) (2000 - 2020)
Company Filing History:
15 out of 3,684 
1 out of 1,455 
Years Active: 2000-2020
Title: S David Kimball: Innovator in Metabolic Disease and Cancer Treatment
Introduction
S David Kimball is a prominent inventor based in East Windsor, NJ (US), known for his significant contributions to the fields of metabolic diseases and cancer treatment. With a total of 16 patents to his name, Kimball has made remarkable strides in developing innovative solutions that address critical health challenges.
Latest Patents
Among his latest patents, Kimball has developed mitochondrial uncouplers for the treatment of metabolic diseases and cancer. This includes the invention of 2-hydroxy-benzoic anilide compounds and derivatives, along with compositions and methods for treating these diseases through the uncoupling of mitochondria. Additionally, he has created a process for preparing azacycloalkanoylaminothiazoles (LD 137e), which relates to new and efficient processes for the preparation of 5-(-2-oxyazolylalkylthio)-2-azacycloalkanoylaminothiazole compounds or their pharmaceutically acceptable salts.
Career Highlights
Throughout his career, Kimball has worked with notable organizations, including Bristol-Myers Squibb Company and Rutgers, the State University of New Jersey. His work in these institutions has allowed him to further his research and development efforts in the pharmaceutical field.
Collaborations
Kimball has collaborated with esteemed colleagues such as Kyoung S Kim and Raj N Misra, contributing to a rich exchange of ideas and advancements in their respective fields.
Conclusion
S David Kimball's innovative work in the treatment of metabolic diseases and cancer showcases his dedication to improving health outcomes through scientific research and invention. His contributions continue to influence the medical community and inspire future advancements in healthcare.